Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination

Pharmacology Biochemistry and Behavior

Volumn 57, Issue 4, 1997, Pages 737-748

  Baker, L E ^a   Taylor, M M ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

Amphetamine; Drug discrimination; MDA; MDMA; Mescaline; Rats; Stereoisomers

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; LYSERGIDE; MESCALINE; PSYCHEDELIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG COMPARISON; DRUG DISCRIMINATION; ENANTIOMER; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; STEREOISOMERISM; STIMULUS GENERALIZATION;

2,5-DIMETHOXY-4-METHYLAMPHETAMINE; 3,4-METHYLENEDIOXYAMPHETAMINE; ANIMALS; COCAINE; DISCRIMINATION LEARNING; FOOD; GENERALIZATION (PSYCHOLOGY); HALLUCINOGENS; LYSERGIC ACID DIETHYLAMIDE; MALE; MESCALINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); STEREOISOMERISM;

ANIMALIA;

EID: 0030765148     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00334-6     Document Type: Article

References (25)

1. Baker, L. E; Broadbent, J.; Michael, E. K.; Matthews, C. A.; Metosh, R. B.; West, W. B.; Appel, J. B.: Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA). Behav. Pharm. 6: 263-275; 1995.
2. Broadbent, J.; Appel, J. B.; Michael, E. K.; Ricker, J. H.: Discriminative stimulus effects of the optical stereoisomers of MDA (3,4-methylenedioxyamphetamine). Behav. Pharm. 3:443-454; 1992.
3. Callahan, P. M.; Appel, J. B.: Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline. J. Pharm. Exp. Ther. 246:866-870; 1988.
4. Climko, R. P.; Roehrich, H.; Sweeney, D. R.; Al-Razi, J.: Ecstasy: A review of MDMA and MDA. Intl. J. Psychiat. Med. 16:359-372; 1987.
5. Evans, S. M.; Zancy, J. P.; Johanson, C. E.: Three-choice discrimination among (+)-amphetamine, fenfluramine and saline in pigeons. Pharmacol. Biochem. Behav. 35:971-980; 1990.
6. Extance, K.; Goudie, A. J.: Inter-animal olfactory cues in operant drug discrimination procedures in rat. Psychopharmacology (Berlin) 91:67-73; 1981.
7. Glennon R. A.; Young, R.: Further investigation of the discriminative stimulus properties of MDA. Pharmacol. Biochem. Behav. 20:501-505; 1984.
8. Glennon, R. A.; Young, R.; Rosecrans, J. A.; Anderson, G. M.: Discriminative stimulus properties of MDA analogs. Biol. Psych. 17:807-814; 1982.
9. Glennon, R. A.; Yousif, M.; Patrick, G.: Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Pharmacol. Biochem. Behav. 29:443-449; 1988.
10. Hiramatsu, M; Cho, A. K.: Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely moving rats: An in vivo microdialysis study. Neuropharmacology 29:269-275; 1990.
11. Hiramatsu, M.; Nabeshima, T.; Kameyama, T.; Maeda, Y.; Cho, A. K.: The effect of optical isomers of MDMA on stereotyped behavior in rats. Phamacol. Biochem. Behav. 33:343-347; 1989.
12. 3H]dopamine release from superfused rat brain slices. Eur. J. Pharmacol. 132:269-276; 1986.
13. 2 receptors. Psychopharmacology 88:525-526; 1986.
14. 3H-5-hydroxytryptamine. Pharmacol. Biochem. Behav. 38:505-512; 1991.
15. Nichols, D. E.; Hoffman, A. J.; Oberlender, R. A.; Jacob P. III; Shulgin, A. T.: Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: Representatives of a novel therapeutic class. J. Med. Chem. 29:2009-2015; 1986.
16. Oberlender, R.; Nichols, D. E.: Drug discrimination studies with MDMA and amphetamine. Psychopharmacology (Berlin) 95:71-76; 1988.
17. Peroutka, S. J.; Newman, H.; Harris, H.: Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharm. 1:273-277; 1988.
18. Rosecrans, J. A.; Glennon, R. A.: The effect of MDA and MDMA ("Ecstasy") isomers in combination with pirenpirone on operant responding in mice. Pharmacol. Biochem. Behav. 28:39-42; 1987.
19. Schechter, M. D.: Discriminative Profile of MDMA. Pharmacol. Biochem. Behav. 24:1533-1537; 1986.
20. Schechter, M. D.: Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). Pharmacol. Biochem. Behav. 31:817-824; 1989.
21. Schmidt, C. J.; Levin, J. A.; Lovenberg, W.: In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem. Pharmacol. 36:747-755; 1987.
22. Schmidt, C. J.; Taylor, V. L.: Neurochemical effects of methylenedioxymethamphetamine in the rat: Acute versus long-term changes. In. Peroutka, S. J., ed.: Ecstasy: The clinical, pharmacological, and neurotoxicological effects of the drug MDMA. Boston: Kluwer Academic Publishers; 1990:151-169.
23. 3H]-monoamines into synaptosomes from different regions of rat brain. Biochem. Pharmacol. 36:2297-2303; 1987.
24. Yamamoto, B. K.; Spanos, I. J.: The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur. J. Pharmacol. 148:195-203; 1988.
25. Young, R.; Glennon, R. A.: A 3-lever operant procedure differentiates the stimulus effects of R(-)MDA from S(+)MDA. Society for Neuroscience Abstracts. 19:831; 1993.